GLP-1 users continued to express a desire for foods they consumed less frequently, highlighting a complex interaction between appetite regulation and food preference
Acetate reduces microglia inflammatory signaling in vitro
days 19-21, p = 0.004)
Watch for hyperglycemic episodes, especially in individuals with type 2 diabetes or those who experienced substantial weight reductions on treatment
Eli Lilly manufactures Mounjaro, a tirzepatide used to lower A1C, and Trulicity, a dulaglutide used to treat type 2 diabetes
Biological mechanisms of retatrutide: Activates GLP-1, GIP, and Glucagon receptors Slows stomach emptying, reduces hunger, and lowers food intake Promotes the release of insulin after meals Supports stable blood sugar and increases fat breakdown Helps prevent the metabolic slowdown common in dieting Improves metabolic flexibility and supports long-term fat loss Beyond The Scale Retatrutide isnt just about whats on the scale